Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Artiflex phakic IOL compared to ICL for the correction of high myopia

Poster Details

First Author: B.Zijlmans THE NETHERLANDS

Co Author(s):                        

Abstract Details

Purpose:

Artiflex phakic IOL and ICL are both used to correct high myopia. There is an overlap in inclusion criteria and we wanted to evaluate the peroperative difficulties, postoperative outcome and satisfaction.

Setting:

Between March 2013 and November 2014 all Artiflex and ICL phakic IOLs were implanted in the Rotterdam Eye Hospital.

Methods:

30 eyes in 16 patients were implanted with an Artiflex phakic IOL and 30 eyes in 16 patients were implanted with an ICL phakic IOL to correct high myopia. 75% was female in the Artiflex group with a mean age in this group of 38,1 years old. 56% was female in the ICL group with a mean age in this group of 33 years old.

Results:

In the Artiflex group the mean preoperative refraction was S-9,25 of myopia compared to S-11 in the ICL group. Postoperative the mean refraction was S-0,66 of myopia in the Artiflex group compared to S-0,60 in the ICL group.In the Artiflex group 6 eyes received a toric Artiflex with a reduction of cylinder from 3 diopter to 0,875 diopter. In the ICL group 5 eyes received a toric ICL with a reduction of cylinder from 2,35 diopter to 0,4 diopter postoperatively.

Conclusions:

Both Artiflex and ICL phakic IOLs gave good results in reduction of preoperative high myopia. The range of IOL power to correct very high myopia above S-14 is wider for the ICL. Both Artiflex and ICL phakic IOLs gave good results to correct preoperative astigmatism. With Artiflex it is more visible to get the exact axis. Satisfaction in both groups was perfect. Careful follow-up of the endothelial cell count is necessary in both phakic IOLs and will be performed yearly.

Financial Disclosure:

NONE

Back to Poster listing